Fabtech College Of Pharmacy, Sangola, Solapur, Maharashtra- 413307
Shingles, medically known as herpes zoster, develops when the varicella-zoster virus (VZV) reawakens after lying inactive dorsal root ganglia impacted as a result of the original chickenpox infection. A painful, unilateral vesicular rash that usually only affects one dermatome is the condition's defining feature. The pathogenesis, epidemiology, clinical signs, diagnostic methods, treatment techniques, and possible side effects of herpes zoster, such as postherpetic neuralgia, are all examined in this review article. Risk variables like age, immunosuppression, and underlying comorbidities are given particular consideration. The paper also covers current preventive measures, namely how zoster vaccinations can lower the burden of disease. Herpes zoster is rising as a public health concern with the expansion across the world’s people ages, highlighting that significance about prompt diagnosis, efficient treatment, and preventative measures.
Shingles—scientifically known as herpes zoste , takes its name drived from the Greek words herpein (crawl) and zoster (girdle or belt). The condition develops when becomes active again within the sensory dorsal region or cranial nerve ganglia, leading to a painful, blistering rash along a specific dermatome.
In contrast, varicella (chickenpox), a common paediatric ailment that typically looks like a widespread a first-time infection with Infection by the varicella-zoster virus produces a rash made up of vesicles. [1] The likelihood of HZ increases into those aged more than 50 years, most likely because of the immunosenescence that comes with growing older, but it can happen to anyone, especially those whose cell-mediated immunity is compromised by illness or medication. [2] post-herpetic neuralgia, however, is the most frequent consequence.
The primary method of preventing an infection with the herpes zoster virus is vaccination. [3,4]
Moreover, complications from HZ have the potential to be fatal. There have been reports of HZ reactivation as a possible side effect that can appear after COVID-19 immunization. Options for treatment and vaccination-based prevention are crucial from a clinical standpoint.[5]Herpes zoster usually appears in one or two nearby dermatomes, with the most common locations being the thorax, cervical region, and eyes. Discrete erythema patches give way to clustered the lesions evolve into blisters before form scabs within nearly one to one and-half weeks, although they may need up to a month to fully resolve. These lesions frequently leave behind pain, pigmentation changes, and anesthetic scars.[6]
The most current and best accessible data on the HZ burden of disease must be used to inform healthcare professionals and policymakers.[7]
Fig.No.1:Herpes Zoster
Pain
Patients with postherpetic neuralgia frequently have abnormal sensory function. Almost every patient in one research had scarred, pain-insensitive patches, and the affected dermatome had aberrant sensations of warmth, pain, and light touch. Usually, motion and temperature changes cause pain. These anomalies might be found far beyond the original eruption's boundar (Fig.1).
In a further study, the intensity of the pain was connected with the degree of sensory impairment. Compared to patients with zoster who recover without neuralgia, those who have postherpetic neuralgia typically experience more sensory alterations.[8,9,10]
Neuropathic In acute zoster and postherpetic neuralgia, nerve injury in the peripheral nervous system gives rise to pain. alterations in how Brain and spinal cord processes signals. After such injury, peripheral neurons become hypersensitive to stimuli, may fire spontaneously, and exhibit lowered activation thresholds. Regrowth of nervev fibers, following such damage leads to the growth of nerve sprouts that can also become active on their own firing. Increased peripheral nerve activity is considered to make the dorsal horn hyperexcitable, leading the central nervous system to respond to all inputs in an exaggerated way. These changes are likely so complex that a single treatment approach cannot address every abnormality. [11,12,13]
Historical Background
Herpes zoster, commonly known as shingles, has been recognized for centuries as a distinct clinical entity. Its history can be traced back to ancient medical writings, where it was often confused with other vesicular eruptions such as smallpox and erysipelas.
1. Early Accounts (Prior to the 18th Century)
Ancient Greek and Roman texts have the earliest mentions of illnesses that resemble herpes zoster. The name herpes traces back to the Greek herpein, which translates to “to creep.” and illustrates crawling skin lesions. Although it was unclear how to distinguish shingles from other skin disorders, medical authors like Hippocrates (c. 460–377 BC) and Celsus (25 BC–50 AD) reported vesicular eruptions that might have included shingles.
2. Early Modern to Renaissance
Herpes zoster was commonly mistaken for smallpox and erysipelas, a bacterial ailment, during the Middle Ages. Although doctors observed a painful vesicular rash, they were still unsure that it was viral. French surgeon Ambroise Paré made more thorough clinical investigations of shingles in the 16th century.
3. 18th–19th Century: Distinguishing This Illness from Others
Doctors started differentiating herpes zoster from other eruptive disorders during the 18th century.
A characteristic that is still utilized in diagnosis today is the segmental distribution of herpes zoster along dermatomes, which was described by German physician von Bärensprung in 1863.
4. 20th Century: Viral Cause Found
Early in the 20th century, doctors noticed that children who were exposed to shingles patients acquired chickenpox, which led them to associate herpes zoster with varicella. The virologist Thomas H. Weller, who won the Nobel Prize in 1953, Researchers confirmed that the varicella zoster virus (VZV) is responsible for both chickenpox and shingles. Discovering that shingles arises from the reactivation of VZV lying dormant in sensory ganglia reshaped its clinical interpretation and therapeutic approach. [14,15]
5. The Vaccination Era, Late 20th–21st Century
The 1980s saw the development of antiviral medications like acyclovir, which significantly enhanced treatment results.
To lessen the frequency and intensity of shingles, the first zoster vaccine (Zostavax, live attenuated VZV) was authorized in 2006.
Since its introduction in 2017, the more potent recombinant zoster vaccine (Shingrix) has gained widespread recommendations.[16,17,18]
Phases of herpes zoster
Prodromal stage: pains along the nerve distribution that feel like scorching, tingling, etching, drilling, prickly, and knife-like.
Active stage: Headache, mild fever, and malaise it may arise from hours to several days following the initial appearance of the rash. Within 12 to 24 hours, papules and edema gradually give way to vesicles in the rash over the next 1 to 7 days, these vesicles become pustules. Once the blisters harden and scab over. which peel off within 2 to 3 weeks, they exit behind reddish skin patches that can be either hyperpigmented or hypopigmented. Following the appearance of skin lesions, intraoral lesions may develop. During the active stage, pain or dysesthesia is minimal, but it often recurs during the crusting phase.
Chronic stage PHN: sharp shocks like a tic, persistent deep agony.[19]
Etiology
The genome of the DNA virus VZV codes for roughly 60 different proteins. The virus's entire genome was deciphered in 1986. Actually, out of all the human herpesviruses, this one has the smallest genome. Human (alpha) herpesvirus is the virus's official name. Antiviral medications can target their distinct viral DNA polymerase and double-stranded DNA found in their genome. One essential property of herpes viruses is their capacity to remain inactive within the dorsal root ganglia indefinitely. Cluster of sensory neurons in such trigeminal. [20,21]
The body's diminishing immunity is the primary cause of shingles development. This decrease may occur because of:
As people age naturally, their risk of developing shingles rises. They may also have Hodgkin lymphoma or non-Hodgkin lymphoma. Using steroid medications or chemotherapy reduction of white blood cell counts following stem cell or bone marrow transplants. Either an allogeneic or autologous stem cell transplant will result in roughly the same incidence of shingles overall. One type of medication that is administered to patients following organ transplantation is immuno-suppressive therapy. Being affected by human immunodeficiency virus (HIV) or by acquired immunodeficiency syndrome (AIDS). [22]
Sign and Symptoms
Epidemiology
VZV differs from other human alpha herpes viruses because it is transmitted through the air, with varicella infections typically peaking during the winter and spring months. In addition, VZV can be spread via fomites contaminated with varicella or herpes zoster (HZ) lesions. Since HZ happens as a result of the reactivation of a patient’s own a virus that remains dormant does not exhibit seasonal trends shows up in epidemic waves, and its incidence is generally more stable compared to varicella.[23]
The incidence of HZ is an estimated three cases per 1,000 patient-years, increasing noticeably around lifetime 50. This rate continues to climb with advancing age, reaching about an incidence of 10 cases per 1,000 patient-years the lifetime of 80.[24,25]
Varicella primarily affects children under the age of ten in several temperate countries, and the prevalence of HZ is rather comparable in these nations. However, in many tropical nations, the virus usually strikes Around late adolescence or the early adult years, and the frequency with which varicella occurs in children is low. Therefore, by the time they are 30 years old, such overall percentage among persons who have Varicella rates approximate those found in temperate climates. Data regarding the prevalence of HZ in tropical nations are nonexistent. [26]
Pathogenesis
The highly contagious VZV gains entry into through the respiratory tract, the body quickly infects T lymphocytes within particular pharyngeal lymphatic organs. During such 10–21-day incubation duration, those infection spreads to those dermises leading to the such common vesicular rash about varicella. Most individuals who experience an infection acquire lasting Defense in conflict with manifest subsequent occurrence coming by varicella.
Natural immunity:
This idea that the virus eventually overcomes the skin's innate defense, which is mediated by IFN-α, was developed through Research using VZV-infected SCID-hu mice, which Mice with severe combined immunodeficiency that have received human skin grafts. The virus then spreads to other bodily areas as cell-associated viraemia (among memory T cell ). [27]
Humoral Immunity:
In order to neutralize the cell-free virus, this is crucial. Even though VZV-specific antibodies are produced during an infection, recuperation from varicella does not require this reaction. Varicella in children with congenital agammaglobulinemia is simple, and excess HZ is not linked to other illnesses that are linked to abnormalities in antibody manufacture. [28]
CMI: [Cell mediated immunity]
This is a crucial part of the host's response to varicella since intracellular pathogens must be eliminated by T-cell-mediated immunity, and VZV is a virus that is linked with cells. Therefore, individuals with CMI abnormalities have more severe varicella and HZ, while those with Tcell immunocompromised disease have both higher frequency (age-specific) and more severe HZ. [29]
Risk Factor
There are two to three cases of HZ for every 1,000 individuals in the general community each year. The general population has a 30% lifetime risk, and at least 50% of people who live to be 85 will have had HZ. As people age, their lifetime risk rises; for those over 65, the The odds ratio (OR) is 1.20 (95% CI: 1.10–1.31) for every five-year increment. The most likely because of this is the diminishing VZV-specific CMI. [30]
Researching young persons who get HZ is not necessary because Epidemiological findings indicate that HZ commonly arises in younger populations, yet less frequency than in older people. Younger individuals with HZ should, however, be more suspicious of underlying immunosuppressive disorders. [31] The following standards must to be taken into account for additional research:
HIV risk factors
Those with lower CMIs have significantly greater HZ rates. Transplant recipients and HIV positive patients may have an incidence that is more than ten times higher than that of the general population. [32]
Reactivation
The establishment and maintenance of latency are dependent on transcription products from viral genes, but host factors ultimately decide whether the virus stays latent. There are several possible reactivation triggers, such as that existence of inflammatory substances and these production of the ORF61 protein. Such production of multiple viral genetic arises during both VZV can establish both latent and lytic infections. The product of those ORF61 genetic is essential to trigger these changes from lytic infection and dormancy. During latent viral invasive , six genes are consistently expressed, whereas 71 genetic remain regularly produced over cell-destroying viral invasive. [33]
VZV moves over microtubules in sensory axons to epithelial cells during reactivation, generally absent causing bloodborne virus. One sensory neuron innervates the dermatome, resulting in a rash due to the ensuing skin infection. The sensory nerves most frequently implicated in VZV reactivation are the cervical, thoracic, and trigeminal (cranial) nerves. The afflicted ganglion also exhibits swelling as well as tissue death of another neuron type. These reactivation of VZV in guinea pig neurons appears to be inflammation-related, because exposure to mastocytes extract can provoke reactivation in this model. [34]
VZV reactivation is associated with a decrease in cell-mediated immunity (CMI), either due to immunosuppression or as a natural consequence of aging, since the ability of VZV-specific T cells to proliferate diminishes over time. In such cases, infants can also develop HZ because they are without yet built sufficient VZV-particular CMI—this occurs when mothers contract varicella in the late stages of pregnancy or when the infant acquires varicella during the first year of life . [35,36]
Fig.No. 2 Reactivation of herpes zoster
Diagnosis
HZ might be medically diagnosed after such lesion appears. A herpes virus might be detected from vesicles using a Tzanck smear or electron microscopy (EM), although These tests are incapable of differentiating between varicella-zoster virus and herpes simplex virus. Laboratory techniques for diagnosing atypical herpes zoster include viral culture, skin biopsy, polymerase chain reaction (PCR), and lead detection methods. [37,38] Since PCR can identify virecella zoster viral DNA in vesicular fluid, it is regarded as such more susceptible aa well as accurate detective method to HZ. [39]As an alternative to PCR, DFA is useful. Because of its low cost, quick turnaround, and great sensitivity, it is favoured over cuitural viruses. [40] In patients with HZ myelitis, viral isolation from blood or cerebrospinal fluid (CSF) is not feasible. Consequently, diagnosis depends on the clinical appearance of a rash in the affected dermatome, along with signs of transverse myelitis and spinal magnetic resonance imaging (MRI) findings. [41] A pain of dermatomal lesion accompanied by muscular fatigue can further support the diagnosis of segmental zoster paresis, and the affected area may show acute denervation on electromyography. [42]
Therapy
Antiviral therapy-
The main antiviral drugs used to treat shingles are valacyclovir, acyclovir, and famciclovir; a successful course of antiviral treatment depends on early beginning. According to meta analyses and randomized controlled trials, acyclovir therapy reduces the risk of chronic discomfort. Along with reducing viral shedding, acyclovir also speeds up the healing of rashes and reduces all forms of pain. Acyclovir may not be as successful as famciclovir and valacyclovir, two prodrugs, because to their more convenient dosage and bioavailability profiles. Each is taken three times instead of five times a day. Valacyclovir considerably reduced the median time to resolution of zoster-related discomfort in one trial when compared to acyclovir. It is authorized to treat HZ in healthy individuals with nucleoside analogues acyclovir, famciclovir, and valacyclovir. Individuals with less severe immunocompromised conditions, such as those with solid tumour malignancy or those undergoing corticosteroid therapy, are thought to benefit from oral acyclovir, valacyclovir, and famciclovir. Intravenous acyclovir is a successful treatment for herpes zoster (HZ) in individuals with highly impaired immune systems, to treated for blood cancer on other hand undergoing myeloid tissue transfer. All of these drugs must be taken within 72 hours of the rash appearing and must be taken to lowest owned by 1 weeks .
Antiviral treatment may be more sensible if started during the prodrome phase as opposed to waiting for the rash to appear. Additionally, these medications have minor adverse effects (mostly headache and nausea) and are well tolerated in patients with good renal function. Additionally, the drugs lower the prevalence of postherpetic neuralgia, or PHN.
The following categories are particularly vulnerable to the particular indications for antiviral medication treatment:
The direction of paracetamol, corticosteroids or opioids and codeine and morphine should be initiated early and firmly in the treatment of pain. For seven days, 60 mg of prednisone should be taken daily; after two weeks, the dosage should be halved weekly until it is stopped. The majority of patients who benefit from corticosteroids are over 50. In spite of the scant data supporting their effectiveness, topical analgesics are frequently utilized to treat PHN. The following topical medications are used to treat PHN: capsaicin, geranium oil, lidocaine 5% patch or gel, and acetylsalicylic acid (500 mg in 5 mL of 95% alcohol). A usual prescription is for 0.025% capsaicin cream to be used three or four times a day. Occasionally, antidepressant and anticonvulsant medications must be added to the pain management. This context has seen widespread usage of tricyclic antidepressants, particularly nortriptyline, begin a 25 mg in a day aa well as titrate upward via 25 mg each two to three days based on tolerance, not exceeding 150 mg per day. The two anticonvulsant medications that are prescribed the most frequently are gabapentinoids, which include pregabalin and gabapentin. [43,44,45]
Aroma therapy-
Applying a topical mixture of Calophyllum inophyllum and Ravensara aromatica in a 50/50 ratio is a simple and efficient way to treat shingles using aromatherapy. As far as shingles and herpes are concerned, it works incredibly well. The usage Dr. Jane Buckle recommended using Ravensara from Foraha (Calophyllum inophyllum) to treat shingles and other herpes outbreaks. Ravensara essential oil has shown the highest success rate. According to Len Price, both Tamanu (Calophyllum inophyllum) vegetable oil and Ravensara aromatic essential oil have been effectively used in the treatment of shingles.[46]
Treatment
Nutritional consideration
There is promise in treating HSV-1 and HSV-2 with nutrients like zinc, lysine, vitamin C, and vitamin E. They might therefore also be useful against HZ, albeit the data for this is mainly based on anecdotal anecdotes and conjectural extrapolation.
|
Herbal Drug |
Scientific Name |
Main Active Components |
Therapeutic Action in Herpes Zoster |
Form / Use |
|
Madonna lily |
Lilium candidum |
Flavonoids, saponins, Mucilage |
Smooth inflamed skin, reduce burning and pain |
Topical paste, creame from bulb extract applied on lesions |
|
Reishi mushroom |
Ganoderma lucidum |
Triterpenoids, polysaccharide, Ganoderi acids |
Antiviral (inhibit VZV replication) |
Oral extract |
|
Bi phaya yaw |
Clinacanthus nutans |
Glycosides, flavonoids, Chlorophyll derivatives |
Reduce rash and pain |
Topical leaf extract |
|
Honey |
Natural bee product |
Enzymes, flavonoids, phenolic acids |
Antiviral, antibacterial, Promote wound healing |
Apply honey directly on lesions |
|
Sangre degrado |
Croton lechleri |
Taspine, proanthocyanidins, alkaloids |
Potent antiviral, promote skin regeneration |
Apply diluted latex topically |
|
Alovera |
Aloe baebadensis miller |
Aloin, acemannan, polysaccharides |
Cooling, soothing, Anti-inflammatory |
Apply fresh gel 23 time |
|
St john’s wort |
Hypericum perforatum |
flavonoids |
nerve Pain relief |
Oral extract or oil applied topically |
1) Madonna lily (Liliumcandidum)-
L. candidum is a natural remedy for HZ according to northern Italian traditional folk medicine. Cultivated L. candidum bulbs have shown promising benefits when cooked in olive fat as well a administered outside to HZ lesions in the role of compress. The plant's bulb contains eight spirostanol saponins and two furostanol saponins, which are thought to beresponsible for its therapeutic effects. [47,48]
Fig.No. 3 Madonna lily
2) Reishi fungus (Ganoderma lucidum)-
Several little studies are explored this potential about G. lucidum for managing HZ as well as PHN, either alone or alongside other herbs. In one case study involving 2 HZ individual under care and 2 PHNindividual under care, direction of warm-aqua-dispersible G. lucidum extraction (36–72 gm dry weight per day) was found to significantly reduce pain. [49,50]
Fig. No. 4 Reishi mushroom
3) Bi phaya yaw (Clinacanthus nutans)-
Thailand has traditionally utilised a tiny shrub from Southeast Asia is traditional treatment to various skin factors, including insect and snake bites. It has been shown to be beneficial for HZ in a few modest studies. Compare to the placebo group, the treatment group showed a significantly higher number of patients with lesion crusting by day three and complete healing within seven to ten days (P<0.01); pain scores were much lower. There have been no reports of adverse drug reactions. [51]
Fig. No. 5 Bi phaya yaw
4) Honey /propolis-
In traditional medicine, bee products—more especially, honey and propolis—have been known to help heal wounds since ancient times. These days, both in the lab and in the examination room, their therapeutic qualities for specific herpes viruses are being verified; they might help treat HZ. [52,53]
In a small, nonblind, cross-over research, patients with HSV who applied honey topically instead of acyclovir cream experienced far shorter episode durations and quicker recovery times. In a similar vein, a randomized. After ten days, a significantly larger proportion of patients in the propolis group (24/30) had recovered compared to the acyclovir (14/30) and placebo (12/30) groups. These findings align within vitro results research suggesting propolis may have antiviral properties against HSV. [54,55]
Fig. No. 6 Honey / propolis
5) Sangre de grado (Croton lechleri)-
Antiviral activity against Viruses causing influenza, parainfluenza, hepatitis A and B, and herpes simplex one and two has been demonstrated by extracts of Sangre de Grado. [56]
Fig. No. 7 Sangre de grado
6) Aloe (Aloe vera)-
A. vera topical treatment has been widely utilised to promote wound healing. HSV-2 has been demonstrated to be inactivated in vitro by aloe emodin, an anthraquinone made from A. vera. According to a different study, acemannan, another component of aloe, and acyclovir work together to effectively combat HSV in vitro. [57,58]
Fig. No.8 Aloe
7) St John’s wort (Hypricum perforatum)-
Traditional medicine has long acknowledged St. John’s wort as an effective treat for nerve disorders and viral invasive. Its effects on herpes viruses have been examined in several studies, showing promising results. [59,60] Several Hypericum species have demonstrated strong antiviral activity against HSV-1 in vitro. Moreover, extracts of H. perforatum have been shown to be effective against HSV in two double-blind. [61,62]
Fig. No.9 St john’s wort
Core hygiene and dietary measures combined with herbal remedies
CONCLUSION
Reactivation of VZV causes herpes zoster, posing an ongoing public health challenge, particularly in aged and immunocompromised populations, and exhibit in the role of painful blistered lesions parallel to a single skin segment . The disease's characteristic appearance. Postherpetic neuralgia, which significantly lowers quality of life, is one of the worst consequences that might result. For an early diagnosis and successful treatment, a thorough grasp of its pathophysiology, risk factors, and clinical symptoms is crucial.
When started as soon as possible, antiviral therapy remains the mainstay of treatment, decreasing the length and intensity of symptoms as well as the likelihood of persistent discomfort. Topical medications, corticosteroids, and analgesics are examples of adjunctive methods that provide more relief. Complementary therapies, such as natural products like honey and propolis and herbal formulations like Lilium candidum, Ganoderma lucidum, Clinacanthus nutans, Aloe vera, and Hypericum perforatum, have promising therapeutic potential, especially in promoting lesion healing and reducing pain.
The prevalence and burden of the disease have significantly decreased because to preventive measures, particularly inoculation with the recombinant zoster vaccine (Shingrix). A lysinerich and arginine-poor diet, proper vitamin consumption, and appropriate hygiene are examples of lifestyle and nutritional practices that help both prevention and healing.
To sum up, managing herpes zoster necessitates an integrative strategy that incorporates timely antiviral medication, efficient pain management, immunization, and evidence-based alternative remedies. In order to diminish worldwide impact of shingles as well its sequelae, more research into nutritional and herbal remedies as well as wider vaccination campaigns will be essential.
REFERENCES
Vishakha Kholape, Nida Mulla, Dr. Sanjay Bais, A Review Article on: Pathophysiology, Treatment Strategies and Emerging Herbal Remedies of Herpes Zoster, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 12, 78-91. https://doi.org/10.5281/zenodo.17777656
10.5281/zenodo.17777656